Chugai Pharmaceutical : Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
April 28, 2022 at 08:14 am IST
Share
April 28, 2022
Name of listed company:
Chugai Pharmaceutical Co., Ltd.
Code number:
4519 (Prime Market of Tokyo Stock Exchange)
Head office:
1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
President & CEO:
Osamu Okuda
Inquiries to:
Toshiya Sasai
Head of Corporate Communications Dept.
Tel: +81-(0)3-3273-0554
Notice of Completion of Disposal of Treasury Shares as Restricted
Stock Compensation Plan
TOKYO, April 28, 2022--Chugai Pharmaceutical Co., Ltd. announced that disposal of treasury shares was completed today, as we announced in the press release "Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan" on March 29, 2022. The result of treasury shares is as follows.
1.
Overview of Disposal
(1) Disposal date
April 28, 2022
(2) Class and number of disposed shares
91,300 shares of Common stock of the Company
(3) Disposal price
¥4,158 per share
(4) Total value of disposed shares
¥379,625,400
(5) Allottees and number thereof;
Directors 3
46,600 shares
number of disposed shares
Vice presidents 12
17,800 shares
Employees 110
26,900 shares
###
Attachments
Original Link
Original Document
Permalink
Disclaimer
Chugai Pharmaceutical Co. Ltd. published this content on 28 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2022 02:43:07 UTC.
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).